SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Dell shares surge on record AI server bookings
- 'No panic anywhere' may be the problem, BofA strategists warn
- Kroger cuts same-store sales outlook, keeps earnings guidance
- AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
SOPHiA GENETICS SA (SOPH) Misses Q4 EPS by 15c, Misses on Revenue; Offers FY24 Revenue Guidance
March 5, 2024 6:48 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.37), $0.15 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $17 million versus the consensus estimate of $17.33 million.
GUIDANCE:
SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the... More
